AWA
CELL

Authentikos Wealth Advisory’s PhenomeX Inc. Common Stock CELL Stock Holding History

Authentikos Wealth Advisory’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-20
Closed -$20 – 655
2023
Q3 		$20 Buy
+20
New +$15 ﹤0.01% 649

Authentikos Wealth Advisory's CELL Position: Q4 2023 in Review

Authentikos Wealth Advisory sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2023, closing a stake of 20 shares — an estimated $20 sold.

Authentikos Wealth Advisory first reported a position in CELL in Q3 2023 and held it in 1 quarter. The position peaked at $20 in Q3 2023. 0 funds tracked by Wall St. Rank hold CELL as of Q4 2023.

  • Authentikos Wealth Advisory reported no remaining PhenomeX Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Authentikos Wealth Advisory sold 20 PhenomeX Inc. Common Stock shares in Q4 2023, an estimated $20.
  • Authentikos Wealth Advisory first reported a position in PhenomeX Inc. Common Stock in Q3 2023 and held it in 1 quarter.
  • Authentikos Wealth Advisory's PhenomeX Inc. Common Stock position peaked at $20 in Q3 2023.
  • 0 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2023.

Based on Authentikos Wealth Advisory's 13F filing for Q4 2023, filed 30 Jan 2024.